Articles

By Sheri R. Colberg, PhD: Much of the research on length of life for individuals living with type 1 diabetes is pessimistic, which makes a new study released recently a breath of fresh air. Data were collected for the ongoing nationwide, multicenter, Finnish Diabetic Nephropathy (FinnDiane) Study that tracked the death rate of 2,639 study participants.

Study finds diabetes complications and mortality may be better predicted with elevated 1-hour blood glucose levels compared with 2-hour blood glucose levels.

Congress creates abbreviated licensure pathway for biological products similar to or interchangeable with FDA-approved products.

Severe hypoglycemia in type 2 diabetes was found to be associated with increased cardiac failure and mortality.

Diastolic function begins to decline in early stages of type 2 diabetes.

Research presented at the American Heart Association provided new insight into  two large diabetes drug trials, CANVAS and EMPA-REG OUTCOME.

CGM will be available at lower price, without fingerstick calibration, and can be worn for 10 days with 12-hour warmup.

New study suggests packaged food claims like “reduced in sugar” or “no added sugar” still have sugar levels too high by World Health Organization standards.

New insulin formulation emerges as safe alternative to long-acting insulins and inconsistent glycemic levels, but could have higher risk of cardiovascular events.

Patients who discontinue their daily aspirin for heart disease prevention may be at risk of further complications.